Hasil Pencarian - Sandra Lord

  • Menampilkan 1 - 5 hasil dari 5
Perbaiki Hasil
  1. 1
    Insulin is necessary but not sufficient: changing the therapeutic paradigm in type 1 diabetes [version 1; peer review: 5 approved]

    Insulin is necessary but not sufficient: changing the therapeutic paradigm in type 1 diabetes [version 1; peer review: 5 approved] oleh Sandra Lord, Carla J. Greenbaum

    Diterbitkan 2020-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    A standardized metric to enhance clinical trial design and outcome interpretation in type 1 diabetes

    A standardized metric to enhance clinical trial design and outcome interpretation in type 1 diabetes oleh Alyssa Ylescupidez, Henry T. Bahnson, Colin O’Rourke, Sandra Lord, Cate Speake, Carla J. Greenbaum

    Diterbitkan 2023-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    IL-6–targeted therapies to block the cytokine or its receptor drive distinct alterations in T cell function

    IL-6–targeted therapies to block the cytokine or its receptor drive distinct alterations in T cell function oleh Cate Speake, Tania Habib, Katharina Lambert, Christian Hundhausen, Sandra Lord, Matthew J. Dufort, Samuel O. Skinner, Alex Hu, MacKenzie Kinsman, Britta E. Jones, Megan D. Maerz, Megan Tatum, Anne M. Hocking, Gerald T. Nepom, Carla J. Greenbaum, Jane H. Buckner

    Diterbitkan 2022-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    SARS-CoV-2 mRNA vaccines decouple anti-viral immunity from humoral autoimmunity

    SARS-CoV-2 mRNA vaccines decouple anti-viral immunity from humoral autoimmunity oleh Jillian R. Jaycox, Carolina Lucas, Inci Yildirim, Yile Dai, Eric Y. Wang, Valter Monteiro, Sandra Lord, Jeffrey Carlin, Mariko Kita, Jane H. Buckner, Shuangge Ma, Melissa Campbell, Albert Ko, Saad Omer, Carrie L. Lucas, Cate Speake, Akiko Iwasaki, Aaron M. Ring

    Diterbitkan 2023-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    IL-6 receptor blockade does not slow β cell loss in new-onset type 1 diabetes

    IL-6 receptor blockade does not slow β cell loss in new-onset type 1 diabetes oleh Carla J. Greenbaum, Elisavet Serti, Katharina Lambert, Lia J. Weiner, Sai Kanaparthi, Sandra Lord, Stephen E. Gitelman, Darrell M. Wilson, Jason L. Gaglia, Kurt J. Griffin, William E. Russell, Philip Raskin, Antoinette Moran, Steven M. Willi, Eva Tsalikian, Linda A. DiMeglio, Kevan C. Herold, Wayne V. Moore, Robin Goland, Mark Harris, Maria E. Craig, Desmond A. Schatz, David A. Baidal, Henry Rodriguez, Kristina M. Utzschneider, Hendrik J. Nel, Carol L. Soppe, Karen D. Boyle, Karen Cerosaletti, Lynette Keyes-Elstein, S. Alice Long, Ranjeny Thomas, James G. McNamara, Jane H. Buckner, Srinath Sanda, for the ITN058AI EXTEND Study Team

    Diterbitkan 2021-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: